DE602004013993D1 - R für biologische wirksubstanz zur oralen verabreichung - Google Patents

R für biologische wirksubstanz zur oralen verabreichung

Info

Publication number
DE602004013993D1
DE602004013993D1 DE602004013993T DE602004013993T DE602004013993D1 DE 602004013993 D1 DE602004013993 D1 DE 602004013993D1 DE 602004013993 T DE602004013993 T DE 602004013993T DE 602004013993 T DE602004013993 T DE 602004013993T DE 602004013993 D1 DE602004013993 D1 DE 602004013993D1
Authority
DE
Germany
Prior art keywords
active substance
microcapsules
biologically active
oral administration
adjuvants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004013993T
Other languages
English (en)
Inventor
Gianni Sava
Laura Zorzin
Dario Vojnovic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FOND CARLO E DIRCE CALLERIO ON
Original Assignee
FOND CARLO E DIRCE CALLERIO ON
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FOND CARLO E DIRCE CALLERIO ON filed Critical FOND CARLO E DIRCE CALLERIO ON
Publication of DE602004013993D1 publication Critical patent/DE602004013993D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DE602004013993T 2003-08-06 2004-08-03 R für biologische wirksubstanz zur oralen verabreichung Active DE602004013993D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001617A ITMI20031617A1 (it) 2003-08-06 2003-08-06 Microcapsule a doppio strato di polisaccaridi utilizzabili
PCT/EP2004/051693 WO2005013941A1 (en) 2003-08-06 2004-08-03 Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration

Publications (1)

Publication Number Publication Date
DE602004013993D1 true DE602004013993D1 (de) 2008-07-03

Family

ID=34131210

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004013993T Active DE602004013993D1 (de) 2003-08-06 2004-08-03 R für biologische wirksubstanz zur oralen verabreichung

Country Status (8)

Country Link
US (1) US20060228422A1 (de)
EP (1) EP1663172B1 (de)
AT (1) ATE395909T1 (de)
CA (1) CA2534368A1 (de)
DE (1) DE602004013993D1 (de)
IL (1) IL173481A (de)
IT (1) ITMI20031617A1 (de)
WO (1) WO2005013941A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100460013C (zh) * 2006-09-05 2009-02-11 重庆康卫生物科技有限公司 口服重组幽门螺杆菌疫苗及其制备方法
EP2124605A2 (de) * 2007-01-19 2009-12-02 The Iams Company Zusammensetzung und verfahren für einen stabilisierten empfindlichen bestandteil
CA2674420A1 (en) * 2007-01-19 2008-07-24 The Iams Company Composition and method of stabilized sensitive ingredient
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
IT1395524B1 (it) 2009-09-02 2012-09-28 Fond Carlo E Dirce Callerio Onlus Metodo e apparato per la preparazione di micro-particelle di polisaccaridi
CN101669917B (zh) * 2009-09-23 2013-07-24 中国人民解放军第二军医大学 一种基于“NiMS”系统的氢溴酸东莨菪碱口腔速崩微囊片
US20120009264A1 (en) * 2010-07-08 2012-01-12 Chih-Hui Yang Drug carrier for treating of gastrointestinal ulcer
MX2017013715A (es) 2015-04-28 2018-03-02 Mars Inc Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado.
FR3048884B1 (fr) * 2016-03-18 2021-07-30 Capsulae Composition pour l'administration par voie orale d'au moins un principe actif a un sujet
EP3471706B1 (de) 2016-06-20 2023-12-20 Virbac Orale pharmazeutische zusammensetzung mit einem pharmazeutisch aktiven wirkstoff, mindestens einem kationischen bioadhäsiven polymer und mindestens zwei anionischen polymeren
CN107281159B (zh) * 2017-06-29 2019-12-20 安徽大学 一种具有多层核壳结构的缓释载药微胶囊的制备方法
CN108379565B (zh) * 2018-02-08 2020-12-25 艾伯尔生物科技（重庆）有限公司 抗菌蛋白微胶囊的制备方法及其应用
CN108245670B (zh) * 2018-02-08 2021-01-15 艾伯尔生物科技（重庆）有限公司 抗菌蛋白微胶囊的制备方法及其应用
EP3536312A1 (de) * 2018-03-08 2019-09-11 Erber Aktiengesellschaft Verfahren zur herstellung säureresistenter makrokügelchen mit nanopartikeln und die verwendung der makrokügelchen zum auslösen einer immunantwort
CN109925983B (zh) * 2019-03-08 2021-12-28 紫罗兰家纺科技股份有限公司 基于乳木果油的双层微胶囊及其整理到纺织面料中的方法
WO2020209273A1 (ja) * 2019-04-09 2020-10-15 富士フイルム株式会社 マイクロカプセルの製造方法およびコート液
CN111643377B (zh) * 2020-07-23 2023-08-11 中国热带农业科学院南亚热带作物研究所 一种汉麻油纳米微胶囊及其制备方法和应用
CN115212189A (zh) * 2022-03-30 2022-10-21 江南大学 一种提高壳寡糖口服生物利用度的纳米微球及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1236885A (en) * 1968-09-28 1971-06-23 Fuji Photo Film Co Ltd Method of making multi-wall capsules
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US5116747A (en) * 1989-08-11 1992-05-26 University Of Waterloo Immobilization of biologically active material in capsules prepared from a water-soluble polymer and chitosan acetate
US5562909A (en) * 1993-07-12 1996-10-08 Massachusetts Institute Of Technology Phosphazene polyelectrolytes as immunoadjuvants
DE19830375A1 (de) * 1998-07-08 2000-01-13 K D Pharma Bexbach Gmbh Mikroverkapselte ungesättigte Fettsäure oder Fettsäureverbindung oder Mischung aus Fettsäuren und/oder Fettsäureverbindungen

Also Published As

Publication number Publication date
IL173481A (en) 2010-06-30
EP1663172B1 (de) 2008-05-21
CA2534368A1 (en) 2005-02-17
US20060228422A1 (en) 2006-10-12
IL173481A0 (en) 2006-06-11
WO2005013941A1 (en) 2005-02-17
ITMI20031617A1 (it) 2005-02-07
ATE395909T1 (de) 2008-06-15
EP1663172A1 (de) 2006-06-07

Similar Documents

Publication Publication Date Title
DE602004013993D1 (de) R für biologische wirksubstanz zur oralen verabreichung
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
EA200701519A1 (ru) Живая аттенуированная ротавирусная вакцина для перорального введения
TW200602077A (en) Compositions as adjuvants to improve immune responses to vaccines and methods of use
ATE462449T1 (de) Benutzung von alpha (1,3) -galactosyltransferase exprimierenden allogenen tumorzellen zur impfung gegen tumoren
ATE276758T1 (de) Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
CY1107571T1 (el) Αυξητικος παραγοντας νευρων ως βοηθητικη ουσια εμβολιου
CY1110727T1 (el) Παρασκευασματα θετικων κατα gram βακτηριων για τη θεραπεια ασθενειων που περιλαμβανουν μια ανοσολογικη δυσρυθμιση
EA200601253A1 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
WO2003096990A3 (en) Protein cages for the delivery of medical imaging and therapy
IL173369A (en) Combined pharmaceutical preparation containing g - csf and p1gf effective in stimulating mobilization of peripheral blood progenitor cells
IT1220979B (it) Capsule contenenti un allergene e procedimento per la loro preparazione
WO2003061578A3 (en) Compositions for treatment or prevention of bioterrorism
BR0208675A (pt) Combinação imunoterapêutica para a imunoterapaia de tumores que superexpressam gangliosìdeos, uso da mesma e método para controlar o crescimento e/ou a proliferação de células tumorais que superexpressam gangliosìdeos
EA200800397A1 (ru) Композиции тизанидина и способы лечения с применением композиций
DE60331412D1 (de) Hiv-vakzine und anwendungsverfahren
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
Vit et al. Use of honey in cancer prevention and therapy
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
WO2002094199A3 (en) METHOD OF INCREASING ANTI-NeuGc ANTIBODY LEVELS IN BLOOD
ATE409495T1 (de) Polynukleotide-bindende komplexe die sterolen und saponine enthalten
RU2010134265A (ru) Способ лечения диспепсии у телят
MD3381G2 (ro) Metodă de tratament al parotiditei cronice la copii
AR027738A1 (es) Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas
GB2358352A (en) Bacterial extract as oral adjuvant

Legal Events

Date Code Title Description
8364 No opposition during term of opposition